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When to use stress echocardio-
graphy in the evaluation of patients 
with valvular heart disease
Valve diseases come to attention because a murmur is detected on 
physical examination, but 2-D and Doppler echocardiography is 
superior to physical examination for detecting valve disease and 
should be utilised in the clinical evaluation of patients who have 
cardiac symptoms even in the absence of an audible or “loud” 
murmur on physical examination. Echocardiography is the single 
most useful test for determining the etiology and severity of valve 
disease and is the test of choice for guiding the management of 
patients with valve disease. Hemodynamic consequences of cardiac 
chamber remodelling with changes in ventricular and atrial size and 
function and/or pulmonary pressures commensurate with severe 
stenosis or regurgitation can be assessed by echocardiography and 
used for risk stratification and timing of therapeutic intervention. In 
addition, unsuspected coexistent heart diseases may be diagnosed 
during evaluation of valve disease. 
In symptomatic patients, a resting echocardiogram that shows 
anatomically severe valve disease and associated hemodynamic 
abnormalities usually provides sufficient information to refer the 
patient to surgery.(7,8) Stress testing in those patients is not indi-
cated unless there is a need to assess for hibernating myocardium 
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IntroductIon                                                              
Valvular heart diseases are a major public health problem world-
wide.(1,2) Rheumatic heart disease is the leading cause of valve 
disease in economically developing countries(3-5) and degenerative 
or aging-related valve diseases predominate in economically 
developed countries.(2,6) The majority of valve diseases are chronic 
and left-sided, affecting the mitral and aortic valves. The valves 
become stenosed or regurgitant. The development of symptoms 
(exertional dyspnoea, fatigue, angina, presyncope, syncope) typically 
occurs when the valve disease is severe and the symptoms are 
usually brought on by exertion. However, symptoms may be imper-
ceptible because they can develop gradually and may not be 
reported by the patient, or the patient may be too sedentary to 
develop symptoms. Additionally, some patients with severe valve 
disease remain asymptomatic despite being active. Symptoms 
related to valve disease lead to decreased exercise tolerance and 
impaired quality of life. They may also indicate impending heart 
failure and death if the valve lesion is not corrected. The mainstay 
of treatment of severe valve disease is valvuloplasty (for mitral 
stenosis in suitable candidates) or surgery (valve replacement or 
repair).
stress testing and stress echocardiography are firmly 
established diagnostic tests in the evaluation of patients 
with suspected or known coronary artery disease, but 
less established in the evaluation of patients with valvular 
heart disease. However, there is emerging data supporting 
the incremental benefit of stress testing and stress echo-
cardiography in patients with known valvular heart disease. 
Particular applications include hemodynamic assessment of 
valve function and pulmonary response during exercise-
induced or chemically-induced stress to correlate with the 
patient’s exertional symptoms. In addition, stress testing 
affords the opportunity for functional assessment of ventri-
cular systolic function for prognostication and planning for 




















or left ventricular contractile reserve when planning for surgery. 
Stress testing and stress echocardiography are useful and indicated 
for patients who report exertional symptoms, but who only appear 
to have mild to moderate valve disease at rest that would not be 
expected to cause symptoms. Stress testing is also useful for 
assessing patients who are sedentary and who do not report 
symptoms despite having severe valve disease. 
The discussion below will focus on left-sided native valve diseases 
and clinical situations where stress testing and stress echocardio-
graphy are useful for decision-making.
MItrAl stenosIs                                                           
Mitral stenosis is caused by structural abnormalities of the mitral 
valve apparatus that lead to improper opening of the valve and 
subsequent obstruction to left ventricular filling during diastole.(7,9,10) 
The predominant cause of mitral stenosis is inflammation of the 
mitral valve from rheumatic fever which leads to valvular and/or 
subvalvular thickening and calcification and commissural fusion. As 
the valve narrows the left atrial pressure increases to continue 
driving blood into the left ventricle; a measurable pressure gradient 
develops across the valve during diastole.(7,11) The increased left 
atrial pressure is reflected back into the pulmonary circulation and 
may lead to pulmonary congestion and pulmonary venous and 
even pulmonary arterial hypertension. The associated symptoms 
are dyspnoea and fatigue or pulmonary oedema.(11,12) The normal 
mitral valve area is 4-6cm2 and symptoms usually do not develop 
until the valve area is less than 2.5cm2;(7,13) a valve area >1.5cm2 
usually does not produce symptoms at rest.(14) Development of 
symptoms or pulmonary hypertension in mitral stenosis is asso-
ciated with a poor outcome if left untreated.(12) 
The pressure gradient across the mitral valve is a function of the 
square of the flow across the valve and is dependent on the dia-
stolic filling period.(7,11) Therefore, symptoms in mitral stenosis are 
usually precipitated by an increase in flow or heart rate and the 
degree of valve stenosis at rest may not reflect the true severity of 
obstruction with exercise.(7,14) 
Guidelines for management of mitral stenosis are based on a point 
scale comprised of the mitral valve area, transmitral mean gradient 
and pulmonary artery systolic pressure (Table 1).(7) Severe mitral 
stenosis is defined as a mitral valve area <1cm2, a transmitral 
mean pressure gradient >10mmHg or pulmonary artery systolic 
pressure >50mmHg. Patients with severe mitral stenosis benefit 
from mitral valvuloplasty or surgery.(7)
Mitral valve area (MVA) is determined by the pressure half-time 
(PHT) or continuity equation methods.(15-19) PHT refers to the 
time it takes for the transmitral gradient to reach half of the initial 
peak gradient and is determined by the slope of the continuous 
wave Doppler signal across the stenotic mitral valve. The initial peak 
gradient is higher and the PHT longer with worsening mitral 
stenosis. Mitral valve area is calculated by the formula:     
MVA = 220/PHT
The PHT can be shortened in the presence of severe mitral 
stenosis if there is underlying decreased left atrial compliance since 
the high left atrial pressure may lead to more rapid equalisation of 
left atrial and left ventricular pressures during diastole.(20) Condi-
tions that cause a rapid rise in left ventricular pressure during 
diastole such as the presence of decreased left ventricular 
compliance or severe aortic regurgitation may also lead to a 
shortened PHT and overestimation of mitral valve area (that is, 
underestimation of severity of mitral stenosis).(19) Calculation of the 
mitral valve area using the continuity equation (Figure 1) requires 
measurements of the forward stroke volume from the left ventricular 
outflow tract (LVOT) diameter (D), LVOT time velocity integral 
(TVI), and mitral valve TVI and using the following equation:
MVA = (LVOT D2 X 0.785 X TVILVOT)/TVIMV 
However, this equation should not be used in the presence of 
significant aortic regurgitation because it will result in under-
estimation of the severity of mitral stenosis.(21) Furthermore, severe 
tAble 1:  grading of severity of mitral valve stenosis(7)
 Valve area Mean gradient Pulmonary artery  
   systolic pressure
Mild >1.5cm2 <5mmHg <30mmHg
Moderate 1-1.5cm2 5-10mmHg 30-50mmHg
Severe <1cm2 >10mmHg >50mmHg
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mitral regurgitation can cause overestimation of the severity of 
mitral valve stenosis if this equation is applied.(19) The mitral valve 
area can also be determined directly by planimetry of the mitral 
valve area at the tips of the mitral valve in the parasternal short- 
axis view. The mean transmitral gradient is determined by tracing 
the continuous wave Doppler signal across the stenotic mitral 
valve. If significant mitral regurgitation is present, the increased 
flow results in a higher transmitral gradient. Thus, a comprehen- 
sive evaluation of mitral stenosis should include assessment of the 
severity of mitral regurgitation.
Pulmonary artery systolic pressure (PASP) is estimated from the 
peak velocity of the tricuspid regurgitation (TR) continuous wave 
signal and right atrial pressure (RAP) using the modified Bernoulli 
equation:
PASP = 4 X TR2 + RAP
(RAP is estimated from the size of the inferior vena cava. If the 
diameter of the inferior vena cava decreases by 50% or more 
during inspiration, RAP is usually <10mmHg, and if the diameter 
decreases less than 50%, RAP is usually >10mmHg).(22)
Stress echocardiography for mitral valve stenosis
A symptomatic patient whose resting echocardiogram shows 
severe mitral stenosis is considered to have symptomatic severe 
mitral valve stenosis and stress echocardiography is not indi-
cated.(23)
Patients who appear to have mild to moderate mitral stenosis at 
rest but who report symptoms of dyspnoea or fatigue may have 
another cause for their symptoms (such as lung disease or 
deconditioning), or may have hemodynamically severe mitral 
stenosis during exercise, since 2-D and Doppler hemodynamic 
determination of mild to moderate mitral stenosis at rest may not 
reflect the hemodynamic severity of the stenosis with exercise. 
Symptom-limited stress echocardiography (exercise or dobuta-
mine) is useful in patients with mild to moderate mitral stenosis at 
rest to assess the transmitral mean gradient and pulmonary 
pressures at peak stress in order to establish a link between the 
patient’s exertional symptoms and stress-induced hemodynamic 
abnormalities.(24-30) 
During exercise, a rise in the transmitral mean diastolic gradient 
to >15mmHg along with a rise in pulmonary artery systolic pres-
sure to >60mmHg associated with symptoms identifies a group of 
patients who have hemodynamically severe mitral stenosis and who 
would benefit from mitral balloon valvuloplasty or mitral valve 
surgery.(7,25,31,32) Some of these patients, however, may respond to 
more aggressive medical therapy, which is aimed at blunting the 
heart rate response to exercise. Therefore, exercise stress testing 
may be used to tailor medical therapy. A rise in pulmonary artery 
systolic pressure with exercise without a significant rise in the mean 
diastolic gradient suggests pulmonary disease.(33)
Supine bicycle exercise is preferable to treadmill exercise because 
hemodynamic data can be obtained during each stage of 
exercise.(28,31,33) The development of a mean gradient ≥18 mmHg 
with dobutamine stress in patients with non-severe mitral stenosis 
at rest identifies a group at high risk of developing subsequent 
dyspnoea or pulmonary oedema requiring hospitalisation, subse-
quent arrhythmias, or requiring mitral valve interventions.(34) Table 2 
outlines variables that should be obtained at rest and during stress 
for clinical decision making. Additionally, colour flow imaging of the 
mitral valve is recommended because the severity of regurgitation 
can increase with exercise in patients with mixed mitral valve 
disease. The mitral valve area is not expected to change much from 
rest to stress, although it can be calculated accurately with the 
continuity equation or by planimetry.(30,35,36) The PHT during stress 
may be inaccurate for estimating valve area.(25,28,37-39) Exercise echo-
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cardiography can also be used to assess haemodynamics after 
mitral valve balloon valvuloplasty.(40)
MItrAl reGurGItAtIon                                                         
Unlike mitral valve stenosis, which is almost always caused by 
rheumatic carditis, the predominant causes of mitral valve regur-
gitation differ between developing and developed countries. 
Rheumatic carditis remains the major cause of mitral regurgitation 
in developing countries and is the predominant cause of heart 
failure in children and young adults with active rheumatic carditis.(41) 
In developed countries, mitral regurgitation is most commonly 
related to degenerative mitral valve disease often associated with 
aging.(2) Another important cause of mitral regurgitation is functional 
mitral regurgitation related to ischaemic or non-ischaemic cardio-
myopathy, but the relative global distribution of this etiology of 
mitral regurgitation is unknown. 
Severity of mitral valve regurgitation is determined by a variety of 
methods including qualitative, semi-quantitative, and quantitative 
measurements (Table 3).(42) The reader is referred to the American 
Society of Echocardiography Recommendations for evaluation of 
the severity of native valvular regurgitation with two-dimensional 
and Doppler echocardiography(42) for complete details of the cri-
teria including their utility, advantages, and limitations. In asympto-
matic patients, quantitative grading of mitral regurgitation is a 
powerful predictor of subsequent atrial fibrillation, heart failure, 
or death where the effective regurgitant orifice (ERO) surpasses 
all other qualitative or quantitative measurements as a prog-
nosticator.(43) 
Stress echocardiography in mitral valve regurgitation
rheumatic mitral regurgitation
Severe mitral regurgitation from rheumatic carditis is typically 
associated with symptoms of dyspnoea, fatigue, or heart failure. 
Surgery is indicated for symptomatic patients with severe rheu-
matic mitral regurgitation and there is no role for stress testing. 
Patients who report symptoms, but who appear to have mild to 
moderate mitral regurgitation at rest should undergo symptom-
limited exercise echocardiography to determine whether the 
mitral regurgitation severity increases with exercise and if pul-
monary hypertension develops (pulmonary artery systolic pressure 
>60 mmHg).(7,33) An increase in the severity of mitral regurgita- 
tion correlates well with elevation of pulmonary artery systolic 
pressure.(44,45)
tAble 2:  Key data to be acquired at rest and during stress during 
assessment of severity of mitral valve stenosis
 rest stress
Blood pressure x x
Heart rate x x
MVA x 
Mean gradient x x
TR velocity x x
Symptoms x x
Exercise duration  x
tAble 3:  Qualitative and quantitative parameters for grading mitral 
regurgitation severity (with permission from the American 
Society of Echocardiography)(42)
CW = continuous-wave. LA = left atrium. ERO = effective regurgitant orifice. 
LV = left ventricle. PW = pulsed-wave. RF = regurgitant fraction. R Vol = regurgitant volume. 
VC = vena contracta.
* Usually above 50 years of age or in conditions of impaired relaxation, in the absence of 
mitral stenosis or other causes of elevated LA pressure.
 Mild Moderate severe
Structural parameters   
LA size Normal Normal or dilated Usually dilated
LV size Normal Normal or dilated Usually dilated
Mitral leaflets or Normal or  Normal or  Abnormal/flail  
supporting structures abnormal abnormal leaflet/Ruptured  
   papillary muscle
Doppler parameters   
Colour flow jet Small central jet Variable Large central jet
(at Nyquist limit of  (usually <4cm2  (usually >10cm2 
50-60cm/s) or <20% of   or >40% of 
 LA area)   LA area) or  
   variable size wall- 
   impinging jet  
   swirling in LA
Mitral inflow-PW A-wave dominant* Variable E-wave dominant* 
   (E usually >1.2 m/s)
Jet density-CW Incomplete or faint Dense Dense
Jet contour-CW Parabolic Usually parabolic Early peaking- 
   triangular
Pulmonary vein flow Systolic dominance Systolic blunting Systolic reversal  
  may be present may be present
Quantitative parameters   
VC width (cm) <0.3 0.3-0.69 ≥0.7
R Vol (ml/beat) <30 30-59 ≥60
RF (%) <30 30-49 ≥50
ERO (cm2) <0.20 0.20-0.39 ≥0.40
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Supine bicycle exercise is the preferred stress testing modality 
because the severity of mitral regurgitation can be assessed at every 
stage of exercise. Qualitative and semi-quantitative measurements 
are easier to obtain during stress testing, but attempts should be 
made to assess severity of regurgitation by quantitative measure-
ments as well.(42) 
Tischler et al. reported a high incidence of exercise-induced 
worsening of mitral regurgitation in a group of patients with 
exertional dyspnoea but with only mild rheumatic mitral valve 
disease at rest (mild stenosis and mild regurgitation).(44) The 
mechanism responsible for this increase in severity of mitral 
regurgitation in patients with rheumatic mitral valve disease is 
unclear.
Degenerative mitral regurgitation
Symptomatic patients with severe mitral regurgitation due to mitral 
valve prolapse or flail mitral valve leaflets should be referred to 
surgery. The preferred mode of surgical correction is mitral valve 
repair instead of mitral valve replacement.(7,43,46) There is no 
indication for stress echocardiography in symptomatic patients 
with severe degenerative mitral regurgitation. Asymptomatic 
patients with overt signs of left ventricular dysfunction (left ven-
tricular ejection fraction ≤60% and left ventricular end-systolic 
dimension ≥40mm) should also be referred for mitral repair ; 
there is no role of stress testing in these patients.(7,8)
There is some debate regarding whether asymptomatic patients 
with severe degenerative mitral valve regurgitation and preserved 
left ventricular size and systolic function (not meeting and exceeding 
guideline cut-off values) should be referred to surgery. We favour 
mitral valve repair in these patients given the unavoidable con-
sequences if left unoperated and the extremely low operative risk 
and excellent long term outcome of these patients. However, the 
surgery should be performed at centres with expertise and high 
success rates in mitral valve repair.(43,47-50) 
Exercise testing in asymptomatic patients with severe mitral 
regurgitation with preserved left ventricular size and systolic 
function may help identify those with decreased exercise capacity 
due to mitral regurgitation and those with latent left ventricular 
dysfunction. The goal of stress testing in these patients is therefore 
to assess functional capacity and response of left ventricular size 
and systolic function to exercise. Decreased exercise capacity in 
asymptomatic patients (peak VO2 <84% predicted), as assessed by 
cardiopulmonary exercise testing, identifies a subgroup at higher 
risk of developing subsequent heart failure or dying.(51) Exercise 
duration of <15 minutes on a modified Bruce protocol in 
asymptomatic patients with severe mitral regurgitation is asso-
ciated with a much higher risk of developing left ventricular 
dysfunction or symptoms (average annual event risk of 23.5% 
versus 4.6% in those with exercise duration ≥15 minutes).(52)
The inability to increase left ventricular ejection fraction ≥4% with 
exercise (that is, lack of contractile reserve) identifies patients 
with latent left ventricular dysfunction.(53-55) These patients are at 
higher risk of developing overt left ventricular dysfunction when 
treated medically and at higher risk of developing postoperative 
heart failure.(54,55) An exercise left-ventricular systolic volume index 
>25ml/m2 in minimally symptomatic patients identifies those at risk 
of developing postoperative heart failure. Depressed longitudinal 
myocardial function assessed by 2-D speckle tracking at rest and 
during exercise was able to identify a subgroup of patients with 
latent left ventricular dysfunction and predicted postoperative left 
ventricular dysfunction.(56)
Ischaemic mitral regurgitation
The mechanism of ischaemic mitral regurgitation is related to 
global and regional remodelling of the left ventricle from ischaemia 
or infarction. This leads to apical and posterior displacement of the 
papillary muscles, tenting of the mitral valve leaflets, loss of annular 
contraction and resultant mitral leaflet malcoaptation and regur-
gitation.(57,58) Mitral regurgitation is present in up to 50% of patients 
following myocardial infarction(59) and is associated with poor 
long term outcome even when the regurgitation is mild; the 
outcome is worse still when the regurgitation is moderate or 
more.(60) Lesion severity in terms of the ERO and regurgitant 
volume that impact negatively on survival in ischaemic mitral 
regurgitation is much less than that of organic or degenerative 
mitral regurgitation (ERO≥20mm2 and regurgitant volume ≥30ml 
are considered severe regurgitation in ischaemic mitral regurgi-
tation).(60) Mitral valve surgery is recommended in patients who 
have severe mitral regurgitation and impaired left ventricular 
ejection fraction who are to undergo coronary bypass surgery.(8) 



















Mitral valve repair, however, does not appear to be superior to 
mitral valve replacement in patients with ischaemic mitral regur-
gitation.(61,62) Surgery solely for mitral regurgitation in patients with 
ischaemic mitral regurgitation and impaired left ventricular systolic 
function does not seem to offer survival benefit,(63-65) but may be 
considered for relief of symptoms in those with associated heart 
failure refractory to medical therapy.(66)
In some patients, mild to moderate ischaemic mitral regurgitation 
may become severe with exercise and these patients are at higher 
risk of heart failure or death.(67-69) Ischaemic mitral regurgitation 
that worsens with exercise and the development of pulmonary 
hypertension with exercise are indeed important causes of acute 
pulmonary oedema in patients with left ventricular systolic dys-
function.(69) Exercise Doppler echocardiography may therefore be 
helpful in elucidating the etiology of exertional symptoms or acute 
pulmonary oedema in patients with mild to moderate mitral 
regurgitation at rest.(69-72) Worsening of the degree of mitral regur-
gitation during exercise is related to changes in local left ventri- 
cular remodelling and more deformation of the mitral valve 
apparatus leading to systolic expansion of the mitral annulus which 
increases the regurgitant orifice.(67)
Dobutamine stress testing in patients with ischaemic mitral 
regurgitation is useful for determining the presence and extent of 
hibernating viable myocardium(73) since treatment of viable hiber-
nating myocardium with revascularisation or medical therapy or 
cardiac resynchronisation may improve both left ventricular systolic 
function and mitral regurgitation.(74-77) 
Non-ischaemic functional mitral regurgitation
The mechanism of mitral regurgitation in non-ischaemic dilated 
cardiomyopathy has also been described and is related to mitral 
leaflet tethering, annular expansion, and decrease in left ventricular 
driving forces that close the mitral valve leaflets.(78) Mitral regur-
gitation is common among patients with non-ischaemic dilated 
cardiomyopathy and its presence impacts negatively on survival 
with the worst survival being in those patients with moderate to 
severe regurgitation.(79) Even patients with mild degree or regur-
gitation have a less favourable outcome compared to those with-
out any mitral regurgitation.(79) As in ischaemic mitral regurgitation, 
a potential reason for why even mild degrees of functional mitral 
regurgitation are associated with poor outcome may be related to 
the dynamic nature of mitral regurgitation, where mitral regurgitation 
worsens with exercise.(58) Yamano et al., using exercise echo-
cardiography, demonstrated exercise-induced changes in functional 
mitral regurgitation in patients with non-ischaemic dilated cardio-
myopathy (Figure 2) and this correlated strongly with exercise 
intolerance.(80) 
Dobutamine changes loading conditions and usually decreases the 
severity of mitral regurgitation by, among other things, decreasing 
mitral ERO(81) and increasing forward left ventricular stroke 
volume.(82) Dobutamine is therefore not considered a useful stress 
testing modality for the assessment of mitral regurgitation. Exer- 
cise, and not dobutamine, should be the stress modality when 
assessing whether the severity of mitral regurgitation, regardless of 
etiology, increases with stress.
AortIc stenosIs                                                            
Aortic valve stenosis may be caused by rheumatic carditis, but it is 
more commonly caused by an atherosclerotic and inflammatory 
process related to aging and cardiovascular risk factors (commonly 
referred to as degenerative aortic valve stenosis).(2,6,83-87) Criteria 
for severity of aortic valve stenosis are outlined in Table 4. 
FIGure 2: colour Doppler echocardiograms of a patient who 
showed an increase in functional Mr severity during exercise. the 
radius of the proximal isovelocity surface area (r) increased from 
4.8 to 7.6mm (right) and the Ero from 14.2 to 29.1mm2 (with 
permission)(80)
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Aortic valve area (AVA) (Figure 3) is calculated from the continuity 
equation which requires measurements of the forward stroke 
volume from LVOT diameter (D), LVOT TVI, and transvalvular TVI 
using the following equation: 
AVA = (LVOT D2 X 0.785 X TVILVOT)/TVIAV
A dimensionless index TVILVOT/TVIAV can also be used in cases 
where the diameter of the LVOT is difficult to measure. A TVILVOT/
TVIAV <0.25 is consistent with severe aortic stenosis.
(7) Symptoms 
related to aortic stenosis (dyspnoea, angina, and syncope being 
the classic triad)(88) typically develop when the degree of aortic 
stenosis is severe. Prompt surgery is indicated in symptomatic 
severe aortic stenosis(89) and there is no indication for stress 
testing.(7,8) Surgery is also recommended for patients with asymp-
tomatic severe aortic stenosis with left ventricular systolic dys-
function (left ventricular ejection fraction <50%).(7,8) Patients with 
moderate aortic stenosis should undergo aortic valve replacement 
if they are having open heart surgery for other reasons.(7,8)
Stress echocardiography in aortic valve stenosis
Aortic stenosis with normal left ventricular systolic function
Surgery is not generally recommended for asymptomatic patients 
with severe aortic valve stenosis until they develop symptoms. 
However, about 30% of asymptomatic patients will develop 
symptoms or heart failure within two years of diagnosis.(90,91) The 
risk of sudden death in asymptomatic patients with severe aortic 
stenosis is <1% per year(92,93) and some asymptomatic patients with 
severe aortic stenosis may develop irreversible left ventricular 
dysfunction, although there is no reliable data to suggest that irre-
versible left ventricular dysfunction develops as a result of severe 
aortic stenosis in the absence of symptoms.(8) The risk of adverse 
outcomes with aortic valve replacement on the other hand is 
about 3-5% and therefore aortic valve replacement is not 
recommended routinely for asymptomatic patients with severe 
aortic stenosis.(7,8) Several predictors of progression of aortic 
stenosis and poor outcome in initially asymptomatic patients have 
been described and include the degree of aortic valve calcification 
(moderate or more),(94) peak jet velocity across the aortic valve 
(peak velocity >4.0m/sec),(92,95) and a higher rate of hemodyna- 
mic progression (increase in peak velocity across the aortic valve 
>0.3m/s per year or decrease in aortic valve area >0.1cm2 per 
year.(94,95) 
Exercise testing is useful in asymptomatic patients with severe 
aortic stenosis to help identify those patients at higher risk of 
developing symptoms and heart failure during follow up. More- 
over, this may identify patients who are not truly asymptomatic. 
Exercise treadmill testing has been shown to be safe in patients 
with asymptomatic severe aortic stenosis, but it has to be per-
formed under careful and close physician supervision.(96-101) Pre-
dictors of the development of symptoms include symptoms during 
exercise testing, an abnormal blood pressure response to exercise 
(<20mmHg increase in systolic blood pressure) and the develop-
ment of ST segment depression ≥2mm.(98,99)
An increase in the mean systolic Doppler gradient ≥18mmHg 
during exercise echocardiography was shown to have incremental 
prognostic value over resting echocardiography and exercise 
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tAble 4:  grading of severity of aortic valve stenosis(7)
 Valve area Valve area Peak velocity  Mean
  index  gradient 
Mild >1.5cm2  <3m/s <25
Moderate 1-1.5cm2  3-4m/s 25-40mmHg
Severe <1cm2 <0.6cm2/m2 >4m/s >40mmHg
























treadmill data in predicting higher risk of developing symptoms, 
heart failure, needing aortic valve replacement, or cardiac death.(101) 
(Figure 4)
Aortic stenosis with reduced left ventricular systolic function 
As previously mentioned, patients who have severe aortic valve 
stenosis (AVA <1cm2 and mean gradient >40mmHg) and reduced 
left ventricular systolic function (LV EF <50%) should be referred 
for surgery.(7,8) 
However, some patients with reduced left ventricular systolic 
function (EF <40%) may present with a calculated AVA ≤1cm2 and 
a low transvalvular mean gradient (<30mmHg), a situation termed 
low gradient, low output aortic stenosis where the transvalvular 
gradient is discordant with the calculated valve area.(102) In this 
setting, there may be fixed, severe aortic stenosis which has 
resulted in left ventricular systolic failure with reduced contractility 
and stroke volume and a low transvalvular gradient. On the other 
hand, both the calculated aortic valve area and transvalvular 
mean gradient may be low because of reduced left ventricular 
contractility and stroke volume from other causes and the stenosis 
is only mild or moderate (“relative” aortic stenosis).(102) The two 
situations can be distinguished from each other by use of low to 
intermediate dose dobutamine echocardiography. In fixed, severe 
aortic stenosis an infusion of dobutamine will result in increased 
contractility and stroke volume and a higher mean transvalvular 
gradient, while the calculated aortic valve area does not change 
significantly. If the aortic stenosis is not severe, with the increased 
left ventricular contractility and stroke volume the aortic valve will 
open more and the valve area increases, while the mean gradient 
remains unchanged or only increases modestly. It is important to 
make the distinction between these two types of patients because 
those with fixed, severe aortic stenosis will benefit from aortic 
valve surgery, while those with relative aortic stenosis will not.(102) 
Therefore, dobutamine echocardiography is particularly helpful in 
patients with aortic stenosis with left ventricular systolic dysfunc-
tion and low transvalvular mean gradients.(103) 
Since the main purpose of using dobutamine in this situation is 
to increase transvalvular flow and not to induce myocardial 
ischaemia,(73) the incremental infusion of dobutamine stops at 
20ug/kg/min. Longer dobutamine infusion stages (up to 5 to 8 
minutes) are recommended to avoid rapid increases in heart rate 
and also to allow for steady-state conditions to be reached and for 
careful data acquisition.(73) Patients who have true fixed, severe 
aortic stenosis and left ventricular contractile reserve, defined as 
an increase in stroke volume ≥20% during dobutamine echo-
cardiography, have a much better postoperative outcome than 
those without contractile reserve (stroke volume increase 
<20%).(104-106) However, patients without left ventricular con- 
tractile reserve should still be considered for aortic valve 
replacement surgery, even though their surgical risk is higher,(107,108) 
since the outlook without surgery is dismal. A significant number 
of patients with aortic stenosis will have coronary artery 
disease(109) and assessment for coexistent coronary artery disease 
in these patients should be by coronary angiography.
AortIc reGurGItAtIon                                               
Aortic regurgitation may be due to the sequelae of rheumatic 
carditis or may be secondary to congenital abnormalities of the 
valve such as bicuspid aortic valve with prolapse or quadricuspid 
aortic valve. Diseases of the aorta that lead to dilatation or 
inflammation of the aorta may also result in aortic regurgitation. 
Acute severe aortic regurgitation, which may occur as a result of 
aortic valve endocarditis or aortic dissection or blunt trauma, 
Rest Echo +  
Ex ECG
Rest Echo +  
Ex ECG + Ex Echo
FIGure 4: Incremental prognostic value of exercise Doppler 
echocardiography over resting echocardiographic and exercise 
electrocardiographic parameters in patients with asymptomatic 
aortic stenosis (with permission)(101)












needs to be treated promptly with aortic valve surgery. On the 
other hand, chronic severe aortic valve regurgitation is usually well 
tolerated and the patient may remain asymptomatic for a long 
time. Surgery is recommended for patients with symptoms attri-
butable to severe aortic regurgitation whether or not there is left 
ventricular systolic dysfunction. In asymptomatic patients, surgery is 
recommended when there are signs of left ventricular systolic 
dysfunction defined as left ventricular ejection fraction ≤50% or 
when there is severe left ventricular dilatation (left ventricular end-
diastolic diameter >75mm or end-systolic diameter >55mm)(7) 
Several qualitative and quantitative measurements are used to 
grade severity of aortic regurgitation (Table 5). The reader is 
referred to the American Society of Echocardiography’s Recom-
mendations for evaluation of the severity of native valvular 
regurgitation with two-dimensional and Doppler echocardio-
graphy(42) for complete details of the criteria including their utility, 
advantages, and limitations.
Stress echocardiography in aortic regurgitation
Aortic valve replacement is not indicated in patients with severe 
aortic regurgitation who are asymptomatic and who have normal 
left ventricular systolic function and no evidence of severe left 
ventricular dilatation. These patients can however develop latent 
left ventricular systolic dysfunction even in the absence of 
decreased systolic function at rest or significant ventricular dilata-
tion. The response of left ventricular ejection fraction to exercise 
or dobutamine has been shown to be an important determinant 
of later development of overt left ventricular systolic dysfunction 
and a predictor of left ventricular functional recovery following 
aortic valve surgery.(110-112) Therefore, stress echocardiography can 
be a useful adjunct in the serial evaluation of patients with asympto-
matic severe aortic regurgitation. Wahi et al showed that con-
tractile reserve on exercise echocardiography was a better pre-
dictor of subsequent left ventricular decompensation in patients 
treated medically and correlated better with resting left ventri- 
cular ejection fraction following aortic valve surgery.(110) Impaired 
left ventricular contractile reserve assessed by low dose dobu-
tamine echocardiography has also been shown to be a marker of 
irreversible left ventricular systolic dysfunction in patients under-
going aortic valve replacement for minimally symptomatic chronic 
severe aortic regurgitation.(111)
conclusIon                                                                   
Stress echocardiography can be a very useful, integral part of the 
evaluation of patients with valvular heart disease. Its main applica-
tions are to evaluate the hemodynamic response to stress to help 
link exertional symptoms to underlying valve disease in patients 
who appear to have mild to moderate disease at rest, or, in the 
case of an “asymptomatic” patient with severe valve disease, to 
determine if limiting symptoms are indeed present. Stress 
echocardiography can unmask latent left ventricular systolic dys-
function in seemingly normal left ventricles at rest, determine 
whether there is contractile reserve in those with reduced left 
ventricular systolic function, and determine the presence and extent 
of viable hibernating myocardium in patients with depressed left 
ventricular systolic function, particularly in patients with ischaemic 
mitral regurgitation. An abnormal left ventricular response to 
exercise is an important predictor of subsequent systolic dysfunc-
tion and left ventricular recovery following valve surgery. 
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tAble 5:  Qualitative and quantitative parameters useful in grading 
aortic regurgitation severity (with permission from the 
American Society of Echocardiography)(42)
AR = aortic regurgitation. CSA = cross sectional area. CW = continuous wave doppler.
EROA = effective regurgitant orifice area. LV = left ventricle. LVOT = left ventricular outflow 
tract. PHT = pressure half-time. PW = pulsed wave doppler. R Vol = regurgitant volume.
RF = regurgitant fraction. VC = vena contracta.
 Mild Moderate severe
Structural parameters   
LV size Normal Normal or dilated Usually dilated
Aortic leaflets  Normal or  Normal or Abnormal/prolapse
 abnormal abnormal or wide coaptation  
   defect
Doppler parameters   
Jet width in LVOT- Small in central jets Intermediate Large in central 
Colour Flow   jets. Variable in  
   eccentric jets
Jet density-CW Incomplete of faint Dense Dense
Jet pressure half- Slow >500 500-200 <200 
time, ms
Diastolic flow reversal Brief, early  Intermediate Prominent 
in descending aorta diastolic reversal  holodiastolic  
   reversal
Quantitative parameters   
VC width (cm) <0.3 0.3-0.60 ≥0.6
Jet width/LVOT  <25 25-64 ≥65 
width (%)  
Jet CSA/LVOT  <5 5-59 ≥60 
CSA (%) 
R Vol (ml/beat) <30 30-59 ≥60
RF (%) <30 30-49 ≥50



















There are however, several stress modalities and protocols in 
the literature pertaining to the utility of stress testing and stress 
echocardiography in patients with valvular heart disease. Addi-
tionally, patients studied are not uniform, and there have not 
been any randomised studies. As a result, Class I indications for 
stress testing in patients with valvular heart disease are few, limited 
mainly to mitral stenosis when there is discrepancy between resting 
echocardiographic findings and clinical findings(7) or asymptomatic 
patients with severe aortic stenosis.(8) Emerging data supports the 
integration of stress testing and stress echocardiography into 
decision making for optimal management of patients with valvular 
heart diseases.
reFerences
14. Hugenholtz PG, Ryan TJ, Stein SW, et al. The spectrum of pure mitral stenosis. 
Hemodynamic studies in relation to clinical disability. Am J Cardiol 1962; 
10:773-84.
15. Henry WL, Griffith JM, Michaelis LL, et al. Measurement of mitral orifice area in 
patients with mitral valve disease by real-time, two-dimensional echocardio-
graphy. Circulation 1975;51:827-31.
16. Holen J, Aaslid R, Landmark K, et al. Determination of pressure gradient in mitral 
stenosis with a non-invasive ultrasound Doppler technique. Acta Med Scand 
1976;199:455-60.
17. Nichol PM, Gilbert BW, Kisslo JA. Two-dimensional echocardiographic assess- 
ment of mitral stenosis. Circulation 1977;55:120-8.
18. Hatle L, Brubakk A, Tromsdal A, et al. Non-invasive assessment of pressure drop 
in mitral stenosis by Doppler ultrasound. Br Heart J 1978;40:131-40.
19. Nishimura RA, Miller FA, Jr., Callahan MJ, et al. Doppler echocardiography: theory, 
instrumentation, technique, and application. Mayo Clin Proc 1985;60:321-43.
20. Schwammenthal E, Vered Z, Agranat O, et al. Impact of atrioventricular com-
pliance on pulmonary artery pressure in mitral stenosis: an exercise 
echocardiographic study. Circulation 2000;102:2378-84.
21. Flachskampf FA, Weyman AE, Gillam L, et al. Aortic regurgitation shortens 
Doppler pressure half-time in mitral stenosis: clinical evidence, in vitro simulation 
and theoretic analysis. J Am Coll Cardiol 1990;16:396-404.
22. Kircher BJ, Himelman RB, Schiller NB. Non-invasive estimation of right atrial 
pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 
1990;66:493-6.
23. Decena BF, 3rd, Tischler MD. Stress echocardiography in valvular heart disease. 
Cardiol Clin 1999;17:555-72, ix.
24. Nakhjavan FK, Katz MR, Shedrovilzky H, et al. Hemodynamic effects of exercise, 
catecholamine stimulation and tachycardia in mitral stenosis and sinus rhythm at 
comparable heart rates. Am J Cardiol 1969;23:659-66.
25. Sagar KB, Wann LS, Paulson WJ, et al. Role of exercise Doppler echocardiography 
in isolated mitral stenosis. Chest 1987;92:27-30.
26. Tunick PA, Freedberg RS, Gargiulo A, et al. Exercise Doppler echocardiography 
as an aid to clinical decision-making in mitral valve disease. J Am Soc Echo- 
cardiogr 1992;5:225-30.
27. Cheriex EC, Pieters FA, Janssen JH, et al. Value of exercise Doppler-echocardio-
graphy in patients with mitral stenosis. Int J Cardiol 1994;45:219-26.
28. Wu WC, Aziz GF, Sadaniantz A. The use of stress echocardiography in the 
assessment of mitral valvular disease. Echocardiography 2004;21:451-8.
29. Hecker SL, Zabalgoitia M, Ashline P, et al. Comparison of exercise and dobu-
tamine stress echocardiography in assessing mitral stenosis. Am J Cardiol 
1997;80:1374-7.
30. Mohan JC, Patel AR, Passey R, et al. Is the mitral valve area flow-dependent in 
mitral stenosis? A dobutamine stress echocardiographic study. J Am Coll Cardiol 
2002;40:1809-15.
31. Sicari R, Nihoyannopoulos P, Evangelista A, et al. Stress echocardiography expert 
consensus statement: European Association of Echocardiography (EAE) (a 
registered branch of the ESC). Eur J Echocardiogr 2008;9:415-37.
32. Aviles RJ, Nishimura RA, Pellikka PA, et al. Utility of stress Doppler echocardio-
graphy in patients undergoing percutaneous mitral balloon valvotomy. J Am Soc 
Echocardiogr 2001;14:676-81.
33. Pellikka PA, Nagueh SF, Elhendy AA, et al. American Society of Echocardiography 
recommendations for performance, interpretation, and application of stress 
echocardiography. J Am Soc Echocardiogr 2007;20:1021-41.
34. Reis G, Motta MS, Barbosa MM, et al. Dobutamine stress echocardiography for 
non-invasive assessment and risk stratification of patients with rheumatic mitral 
stenosis. J Am Coll Cardiol 2004;43:393-401.
35. Braverman AC, Thomas JD, Lee RT. Doppler echocardiographic estimation of 
mitral valve area during changing hemodynamic conditions. Am J Cardiol 
1991;68:1485-90.
1. Anonymous. Rheumatic fever and rheumatic heart disease. World Health 
Organisation Technical Report Series 2004;923:1-122.
2. Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: 
a population-based study. Lancet 2006;368:1005-11.
3. Nkomo VT. Epidemiology and prevention of valvular heart diseases and 
infective endocarditis in Africa. Heart 2007;93:1510-9.
4. Carapetis JR, McDonald M, Wilson NJ. Acute rheumatic fever. Lancet 2005; 
366:155-68.
5. Marijon E, Ou P, Celermajer DS, et al. Prevalence of rheumatic heart disease 
detected by echocardiographic screening. N Engl J Med 2007;357:470-6.
6. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular 
heart disease in Europe: The Euro heart survey on valvular heart disease. 
Eur Heart J 2003;24:1231-43.
7. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for 
the management of patients with valvular heart disease: a report of the 
American College of Cardiology/American Heart Association task force on 
practice guidelines (writing committee to revise the 1998 guidelines for the 
management of patients with valvular heart disease) developed in collabora- 
tion with the Society of Cardiovascular Anesthesiologists endorsed by the Society 
for Cardiovascular Angiography and Interventions and the Society of Thoracic 
Surgeons. J Am Coll Cardiol 2006;48:e1-148.
8. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of 
valvular heart disease: The task force on the management of valvular heart 
disease of the European Society of Cardiology. Eur Heart J 2007;28:230-68.
9. Edwards JE, Rusted IE, Scheifley CH. Studies of the mitral valve. II. Certain ana-
tomic features of the mitral valve and associated structures in mitral stenosis. 
Circulation 1956;14:398-406.
10. Roberts WC, Perloff JK. Mitral valvular disease. A clinicopathologic survey of the 
conditions causing the mitral valve to function abnormally. Ann Intern Med 
1972;77:939-75.
11. Braunwald E, Moscovitz HL, Amram SS, et al. The hemodynamics of the left side 
of the heart as studied by simultaneous left atrial, left ventricular, and aortic 
pressures; particular reference to mitral stenosis. Circulation 1955;12:69-81.
12. Wood P. An appreciation of mitral stenosis: II. Investigations and results. Br Med 
J 1954;1:1113-24.
13. Gorlin R, Gorlin SG. Hydraulic formula for calculation of the area of the stenotic 
mitral valve, other cardiac valves, and central circulatory shunts. I. Am Heart J 
1951;41:1-29.
104
VALVE DISEASE AND StrESS EchocArDIogrAphy
55. Lee R, Haluska B, Leung DY, et al. Functional and prognostic implications of left 
ventricular contractile reserve in patients with asymptomatic severe mitral 
regurgitation. Heart 2005;91:1407-12.
56. Lancellotti P, Cosyns B, Zacharakis D, et al. Importance of left ventricular 
longitudinal function and functional reserve in patients with degenerative mitral 
regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echo-
cardiogr 2008;21:1331-6.
57. Yiu SF, Enriquez-Sarano M, Tribouilloy C, et al. Determinants of the degree of 
functional mitral regurgitation in patients with systolic left ventricular dysfunction: 
A quantitative clinical study. Circulation 2000;102:1400-6.
58. Levine RA, Schwammenthal E. Ischaemic mitral regurgitation on the threshold of 
a solution: from paradoxes to unifying concepts. Circulation 2005;112:745-58.
59. Bursi F, Enriquez-Sarano M, Nkomo VT, et al. Heart failure and death after 
myocardial infarction in the community: the emerging role of mitral regurgitation. 
Circulation 2005;111:295-301.
60. Grigioni F, Enriquez-Sarano M, Zehr KJ, et al. Ischaemic mitral regurgitation: 
long-term outcome and prognostic implications with quantitative Doppler assess-
ment. Circulation 2001;103:1759-64.
61. Enriquez-Sarano M, Schaff HV, Frye RL. Mitral regurgitation: what causes the 
leakage is fundamental to the outcome of valve repair. Circulation 2003;108: 
253-6.
62. Magne J, Girerd N, Senechal M, et al. Mitral repair versus replacement for 
ischaemic mitral regurgitation: comparison of short-term and long-term survival. 
Circulation 2009;120:S104-11.
63. McGee EC, Gillinov AM, Blackstone EH, et al. Recurrent mitral regurgitation after 
annuloplasty for functional ischaemic mitral regurgitation. J Thorac Cardiovasc 
Surg 2004;128:916-24.
64. Wu AH, Aaronson KD, Bolling SF, et al. Impact of mitral valve annuloplasty on 
mortality risk in patients with mitral regurgitation and left ventricular systolic 
dysfunction. J Am Coll Cardiol 2005;45:381-7.
65. Mihaljevic T, Lam BK, Rajeswaran J, et al. Impact of mitral valve annuloplasty 
combined with revascularisation in patients with functional ischaemic mitral 
regurgitation. J Am Coll Cardiol 2007;49:2191-201.
66. Rukosujew A, Klotz S, Welp H, et al. Surgery of secondary mitral insufficiency in 
patients with impaired left ventricular function. J Cardiothorac Surg 2009;4:36.
67. Lancellotti P, Lebrun F, Pierard LA. Determinants of exercise-induced changes in 
mitral regurgitation in patients with coronary artery disease and left ventricular 
dysfunction. J Am Coll Cardiol 2003;42:1921-8.
68. Lancellotti P, Troisfontaines P, Toussaint AC, et al. Prognostic importance of 
exercise-induced changes in mitral regurgitation in patients with chronic ischaemic 
left ventricular dysfunction. Circulation 2003;108:1713-7.
69. Pierard LA, Lancellotti P. The role of ischaemic mitral regurgitation in the 
pathogenesis of acute pulmonary oedema. N Engl J Med 2004;351:1627-34.
70. Fehrenbacher G, Schmidt DH, Bommer WJ. Evaluation of transient mitral regur-
gitation in coronary artery disease. Am J Cardiol 1991;68:868-73.
71. Peteiro J, Freire E, Montserrat L, et al. The effect of exercise on ischaemic mitral 
regurgitation. Chest 1998;114:1075-82.
72. Peteiro J, Monserrat L, Bouzas B, et al. Effect of left ventricular global systolic 
function, mitral regurgitation, and left ventricular inflow pattern on exercise 
echocardiography results. Echocardiography 2002;19:115-23.
73. Picano E, Pibarot P, Lancellotti P, et al. The emerging role of exercise testing and 
stress echocardiography in valvular heart disease. J Am Coll Cardiol 2009;54: 
2251-60.
74. Sicari R, Picano E, Cortigiani L, et al. Prognostic value of myocardial viability 
recognised by low-dose dobutamine echocardiography in chronic ischaemic left 
ventricular dysfunction. Am J Cardiol 2003;92:1263-6.
36. Nakatani S, Masuyama T, Kodama K, et al. Value and limitations of Doppler 
echocardiography in the quantification of stenotic mitral valve area: comparison 
of the pressure half-time and the continuity equation methods. Circulation 
1988;77:78-85.
37. Karp K, Teien D, Bjerle P, et al Reassessment of valve area determinations in 
mitral stenosis by the pressure half-time method: impact of left ventricular stiffness 
and peak diastolic pressure difference. J Am Coll Cardiol 1989;13:594-9.
38. Loyd D, Ask P, Wranne B. Pressure half-time does not always predict mitral valve 
area correctly. J Am Soc Echocardiogr 1988;1:313-21.
39. Firstenberg MS, Prior DL, Greenberg NL, et al. Effect of cardiac output on mitral 
valve area in patients with mitral stenosis: validation and pitfalls of the pressure 
half-time method. J Heart Valve Dis 2001;10:49-56.
40. Tamai J, Nagata S, Akaike M, et al. Improvement in mitral flow dynamics during 
exercise after percutaneous transvenous mitral commissurotomy. Non-invasive 
evaluation using continuous wave Doppler technique. Circulation 1990;81:46-51.
41. Essop MR, Wisenbaugh T, Sareli P. Evidence against a myocardial factor as the 
cause of left ventricular dilation in active rheumatic carditis. J Am Coll Cardiol 
1993;22:826-9.
42. Zoghbi WA, Enriquez-Sarano M, Foster E, et al. Recommendations for evaluation 
of the severity of native valvular regurgitation with two-dimensional and Doppler 
echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
43. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative deter-
minants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 
2005;352:875-83.
44. Tischler MD, Battle RW, Saha M, et al. Observations suggesting a high incidence 
of exercise-induced severe mitral regurgitation in patients with mild rheumatic 
mitral valve disease at rest. J Am Coll Cardiol 1995;25:128-33.
45. Lebrun F, Lancellotti P, Pierard LA. Quantitation of functional mitral regurgi- 
tation during bicycle exercise in patients with heart failure. J Am Coll Cardiol 
2001;38:1685-92.
46. Ling LH, Enriquez-Sarano M, Seward JB, et al. Clinical outcome of mitral regurgi-
tation due to flail leaflet. N Engl J Med 1996;335:1417-23.
47. Ling LH, Enriquez-Sarano M, Seward JB, et al. Early surgery in patients with 
mitral regurgitation due to flail leaflets: a long-term outcome study. Circulation 
1997;96:1819-25.
48. Suri RM, Schaff HV, Dearani JA, et al. Recurrent mitral regurgitation after repair : 
should the mitral valve be re-repaired? J Thorac Cardiovasc Surg 2006;132: 
1390-7.
49. Suri RM, Schaff HV, Dearani JA, et al. Survival advantage and improved durability 
of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg 
2006;82:819-26.
50. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009; 
373:1382-94.
51. Messika-Zeitoun D, Johnson BD, Nkomo V, et al. Cardiopulmonary exercise testing 
determination of functional capacity in mitral regurgitation: physiologic and 
outcome implications. J Am Coll Cardiol 2006;47:2521-7.
52. Supino PG, Borer JS, Schuleri K, et al. Prognostic value of exercise tolerance 
testing in asymptomatic chronic non-ischaemic mitral regurgitation. Am J Cardiol 
2007;100:1274-81.
53. Haluska BA, Short L, Marwick TH. Relationship of ventricular longitudinal 
function to contractile reserve in patients with mitral regurgitation. Am Heart J 
2003;146:183-8.
54. Leung DY, Griffin BP, Stewart WJ, et al. Left ventricular function after valve repair 
for chronic mitral regurgitation: predictive value of preoperative assessment 





















97. Otto CM, Pearlman AS, Kraft CD, et al. Physiologic changes with maximal 
exercise in asymptomatic valvular aortic stenosis assessed by Doppler echo-
cardiography. J Am Coll Cardiol 1992;20:1160-7.
98. Amato MC, Moffa PJ, Werner KE, et al. Treatment decision in asymptomatic 
aortic valve stenosis: role of exercise testing. Heart 2001;86:381-6.
99. Alborino D, Hoffmann JL, Fournet PC, et al. Value of exercise testing to evaluate 
the indication for surgery in asymptomatic patients with valvular aortic stenosis. 
J Heart Valve Dis 2002;11:204-9.
100. Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. 
Eur Heart J 2005;26:1309-13.
101. Lancellotti P, Lebois F, Simon M, et al. Prognostic importance of quantitative 
exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. 
Circulation 2005;112:I377-82.
102. Burwash IG. Low-flow, low-gradient aortic stenosis: from evaluation to treatment. 
Curr Opin Cardiol 2007;22:84-91.
103. Agricola E, Oppizzi M, Pisani M, et al. Stress echocardiography in heart failure. 
Cardiovasc Ultrasound 2004;2:11.
104. Monin JL, Monchi M, Gest V, et al. Aortic stenosis with severe left ventricular 
dysfunction and low transvalvular pressure gradients: risk stratification by low-
dose dobutamine echocardiography. J Am Coll Cardiol 2001;37:2101-7.
105. Nishimura RA, Grantham JA, Connolly HM, et al. Low-output, low-gradient aortic 
stenosis in patients with depressed left ventricular systolic function: the clinical 
utility of the dobutamine challenge in the catheterisation laboratory. Circulation 
2002;106:809-13.
106. Monin JL, Quere JP, Monchi M, et al. Low-gradient aortic stenosis: operative risk 
stratification and predictors for long-term outcome: a multi-centre study using 
dobutamine stress hemodynamics. Circulation 2003;108:319-24.
107. Tribouilloy C, Levy F, Rusinaru D, et al. Outcome after aortic valve replacement 
for low-flow/low-gradient aortic stenosis without contractile reserve on dobu-
tamine stress echocardiography. J Am Coll Cardiol 2009;53:1865-73.
108. Halkos ME, Chen EP, Sarin EL, et al. Aortic valve replacement for aortic stenosis 
in patients with left ventricular dysfunction. Ann Thorac Surg 2009;88:746-51.
109. Mautner GC, Roberts WC. Reported frequency of coronary arterial narrowing 
by angiogram in patients with valvular aortic stenosis. Am J Cardiol 1992;70: 
539-40.
110. Wahi S, Haluska B, Pasquet A, et al. Exercise echocardiography predicts 
development of left ventricular dysfunction in medically and surgically treated 
patients with asymptomatic severe aortic regurgitation. Heart 2000;84:606-14.
111. Tam JW, Antecol D, Kim HH, et al. Low dose dobutamine echocardiography in 
the assessment of contractile reserve to predict the outcome of valve replace-
ment for chronic aortic regurgitation. Can J Cardiol 1999;15:73-9.
112. Espinola-Zavaleta N, Gomez-Nunez N, Chavez PY, et al. Evaluation of the response 
to pharmacological stress in chronic aortic regurgitation. Echocardiography 
2001;18:491-6.
75. Rizzello V, Poldermans D, Boersma E, et al. Opposite patterns of left ventricular 
remodeling after coronary revascularisation in patients with ischaemic cardio-
myopathy: role of myocardial viability. Circulation 2004;110:2383-8.
76. Schinkel AF, Bax JJ, Poldermans D, et al. Hibernating myocardium: diagnosis and 
patient outcomes. Curr Probl Cardiol 2007;32:375-410.
77. Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation, and assessment of 
myocardial viability. Circulation 2008;117:103-14.
78. He S, Fontaine AA, Schwammenthal E, et al. Integrated mechanism for functional 
mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. 
Circulation 1997;96:1826-34.
79. Trichon BH, Felker GM, Shaw LK, et al. Relation of frequency and severity of 
mitral regurgitation to survival among patients with left ventricular systolic 
dysfunction and heart failure. Am J Cardiol 2003;91:538-43.
80. Yamano T, Nakatani S, Kanzaki H, et al. Exercise-induced changes of functional 
mitral regurgitation in asymptomatic or mildly symptomatic patients with 
idiopathic dilated cardiomyopathy. Am J Cardiol 2008;102:481-5.
81. Keren G, Katz S, Strom J, et al. Dynamic mitral regurgitation. An important deter-
minant of the hemodynamic response to load alterations and inotropic therapy 
in severe heart failure. Circulation 1989;80:306-13.
82. Sonoda M, Takenaka K, Sakamoto T, et al. Effects of dobutamine infusion on 
mitral regurgitation. Echocardiography 1998;15:13-20.
83. Commerford PJ, Curcio A, Albanese M, et al. Aortic valve replacement in the 
elderly. S Afr Med J 1981;59:975-6.
84. Otto CM, Kuusisto J, Reichenbach DD, et al. Characterisation of the early lesion of 
“degenerative” valvular aortic stenosis. Histological and immunohistochemical 
studies. Circulation 1994;90:844-53.
85. Olsson M, Dalsgaard CJ, Haegerstrand A, et al. Accumulation of T-lymphocytes 
and expression of interleukin-2 receptors in non-rheumatic stenotic aortic valves. 
J Am Coll Cardiol 1994;23:1162-70.
86. Mohler ER, Sheridan MJ, Nichols R, et al. Development and progression of aortic 
valve stenosis: atherosclerosis risk factors – a causal relationship? A clinical mor-
phologic study. Clin Cardiol 1991;14:995-9.
87. Gotoh T, Kuroda T, Yamasawa M, et al. Correlation between lipoprotein(a) and 
aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and 
Cohort Study). Am J Cardiol 1995;76:928-32.
88. Ross J, Jr., Braunwald E. Aortic stenosis. Circulation 1968;38:61-7.
89. Lund O, Nielsen TT, Emmertsen K, et al. Mortality and worsening of prognostic 
profile during waiting time for valve replacement in aortic stenosis. Thorac 
Cardiovasc Surg 1996;44:289-95.
90. Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. 
J Am Coll Cardiol 2006;47:2141-51.
91. Dal-Bianco JP, Khandheria BK, Mookadam F, et al. Management of asymptomatic 
severe aortic stenosis. J Am Coll Cardiol 2008;52:1279-92.
92. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymp-
tomatic, hemodynamically significant aortic stenosis during prolonged follow-up. 
Circulation 2005;111:3290-5.
93. Coglianese EE, Davidoff R. Predicting outcome in patients with asymptomatic 
aortic stenosis. Circulation 2009;120:9-11.
94. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymp-
tomatic aortic stenosis. N Engl J Med 2000;343:611-7.
95. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic 
valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of 
outcome. Circulation 1997;95:2262-70.
96. Clyne CA, Arrighi JA, Maron BJ, et al. Systemic and left ventricular responses to 
exercise stress in asymptomatic patients with valvular aortic stenosis. Am J Cardiol 
1991;68:1469-76.
